Testing effectiveness (Phase 2)Study completedNCT00106106
What this trial is testing
Acamprosate to Reduce Symptoms of Alcohol Withdrawal
Who this might be right for
Alcohol-Related DisordersAlcohol DependenceAlcoholism+1 more
National Institutes of Health Clinical Center (CC) 56